Results 161 to 170 of about 1,620,741 (300)

Predicting adherence of imatinib in gastrointestinal stromal tumor-rise of the machines! [PDF]

J Gastrointest Oncol
Prasanna T, Yip D.
europepmc   +1 more source

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases

Phytotherapy Research, EarlyView.
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin, Inho Cho, Xue Zhu, Ke Wang, Ling Zhu, Wenchang Wong, Michael Murray, Fanfan Zhou   +7 more
wiley   +1 more source

Rectal Gastrointestinal Stromal Tumor Poor Response to Imatinib: A Case Report. [PDF]

Clin Case Rep
Einakchi M, Samimi A, Zandbaf T, Mesbah N.   +3 more
europepmc   +1 more source

A Recurrent Tympanicum Paraganglioma With a SDHD Pathogenic Variant: Fourth Reported Case

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective The aim of this study is to describe a clinical case of a SDHD germline mutation associated tympanic paraganglioma (TPGL). Patients A female patient seen in the otology clinic at a tertiary care center with a diagnosis of tympanic paraganglioma and significant family history of head and neck paragangliomas.
Alex Z. Graboyes, Kevin Wong, Yonghong Huan, Jason A. Brant   +3 more
wiley   +1 more source

Hemorrhagic Gastrointestinal Stromal Tumor

ACG Case Reports Journal, 2022
Perez Del Nogal, Genesis, Gopal, Purva, Okwara, Chinemerem   +2 more
openaire   +2 more sources

Comparison of nomograms and predictive tools in gastrointestinal stromal tumor. [PDF]

J Gastrointest Oncol
Morocho B, Kwon S.
europepmc   +1 more source

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

The Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo, Akimichi Morita, Yayoi Tada, Shinichi Imafuku, April W. Armstrong, Andrew Blauvelt, John Vaile, Zoran Popmihajlov, Janice Li, Rajesh Sawant, Katsuyoshi Habiro, Katsuki Tsuritani, Mamitaro Ohtsuki   +12 more
wiley   +1 more source

A Case Report and Literature Review of a Rectal Gastrointestinal Stromal Tumor. [PDF]

ACG Case Rep J
Van Ekdom C, Robinson M, Afzal U, Reddy S, Al-Dwairy A, Khouqeer A, Tagouri Y, Chalhoub W.   +7 more
europepmc   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

From Dieulafoy's Lesion to Gastrointestinal Stromal Tumor: A Case of Recurrent Upper Gastrointestinal Bleeding. [PDF]

Cureus
Suliman AHA, Kheruwala A, Barbour A, Eltayeb S, Khassouan A.   +4 more
europepmc   +1 more source